-
1
-
2
Unlocking Dendritic Cell-Based Vaccine Efficacy through Genetic Modulation—How Soon Is Now?
Published 2023-11-01Get full text
Article -
3
-
4
-
5
Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery
Published 2022-01-01Get full text
Article -
6
Gut Microbiota Regulates the Interaction between Diet and Genetics to Influence Glucose Tolerance
Published 2021-07-01Get full text
Article -
7
-
8
Reduction of costs for anemia-management drugs associated with the use of ferric citrate
Published 2014-05-01“…Conclusion: It is likely that US health care costs for anemia-management drugs associated with ESRD among HD patients can be reduced by using ferric citrate as a phosphate binder. …”
Get full text
Article -
9
-
10
Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
Published 2023-06-01Article -
11
Quercetin treatment reduces the severity of renal dysplasia in a beta-catenin dependent manner.
Published 2020-01-01Get full text
Article -
12
The Good and the Bad of SHROOM3 in Kidney Development and Disease: A Narrative Review
Published 2023-12-01Get full text
Article -
13
-
14
Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma
Published 2021-09-01“…Multivariate regression models evaluated associations between cT2 burden score and asthma exacerbations and asthma control. …”
Get full text
Article -
15
-
16
-
17
-
18
-
19
Minimal Kidney Disease Phenotype in Heterozygous Null Mice
Published 2023-06-01Get full text
Article -
20
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
Published 2013-02-01“…Alok A Khorana,1 Mehul R Dalal,2 Jay Lin,3 Gregory C Connolly11Division of Oncology/Hematology, James P Wilmot Cancer Center, University of Rochester, Rochester, NY, 2sanofi-aventis US, Bridgewater, NJ, 3Novosys Health, Flemington, NJ, USABackground: This study examines venous thromboembolism (VTE)-associated resource utilization and real-world costs in ambulatory patients initiating chemotherapy for selected common high-risk solid tumors.Methods: Health care claims data (2004–2009) from the IMS/PharMetrics® Patient-Centric database were collected for propensity score-matched adult cancer (lung, colorectal, pancreatic, gastric, bladder, or ovarian) patients initiating chemotherapy with VTE (n = 912) and without VTE (n = 2736). …”
Get full text
Article